Novavax, Inc. (NVAX)
NASDAQ·Healthcare·Biotechnology
$7.36
-0.20%
Mkt Cap $1.30B
Analyst Ratings
Buy
2
Hold
1
Sell
0
Price Target (8 analysts)
$18.00
Range $11.00 – $25.00
Implied Upside
+144.7%
Consensus $18.00 vs current $7.36
NASDAQ·Healthcare·Biotechnology
$7.36
-0.20%
Mkt Cap $1.30B
Buy
2
Hold
1
Sell
0
Price Target (8 analysts)
$18.00
Range $11.00 – $25.00
+144.7%
Consensus $18.00 vs current $7.36